Dawmed Systems Share Discussion Threads

[alex turner phd] 27/8/2015 22:51

Tracked through.

[jambo172] 22/7/2009 14:54

Wow - some move today.
Somebody somewhere knows something.

[double6] 06/7/2009 15:20

MC now circa £550k.

Cash £800k + Bank Facilities to invest ??

[freestyle] 06/7/2009 12:50

"Following the sale of DIL, DMS will become an investing company for AIM Rules
purposes and its proposed investing policy will require approval by shareholders
of DMS. Following completion of the Sale the Continuing Directors, being Kevin
Gilmore, Gordon Arbib and Nicholas Trigg, propose that, instead of winding up
the Company, the Company's share capital should remain admitted to trading on
AIM and that the Company's New Investing Policy should be based predominantly
upon the acquisition for and development of and/or investment in commercial
property, commercial property agency and the acquisition of land for and
development of high end residential property, together with potential corporate
acquisitions, the latter mainly in the property sector."

So from washer disinfectors to property company, no wonder the market has reacted as such to this!

Best of luck with this move, the market is at a bottom, but I just can't see how a management company which had been higly focussed and qualified in a niche sector can switch and sart making decisions about property acquistion. I think DIL will be wound up in 12-24 months time afetr all the cash has been spent.

Wonder how barclays with their holding feel about this one or if they have advised this move.

[gelp] 05/7/2009 21:07

Sale of Operating Subsidiary (Dawmed Systems)





TIDMDSY

RNS Number : 1325V
DawMed Systems PLC
03 July 2009

?




For Immediate Release
3 July 2009


DawMed Systems plc
("Company")
Sale of Operating Subsidiary


DawMed Systems plc ("DMS") announces that it has today signed a conditional
agreement with Wassenburg & Co B.V. ("Wassenburg") for the sale of all the
issued share capital in DawMed International Limited ("DIL"), DMS' sole
operating subsidiary. The consideration for the sale is the sum of GBP950,000 in
cash (to be paid on completion). Completion accounts will be drawn up as at 1
July 2009 and there will be an adjustment to the consideration on the basis of
DIL's net assets being more or less than GBP75,000. DMS and Wassenburg will each
share 50% of any such shortfall in or excess of net assets.


Whilst the Directors believe that the Second Interim Results were relatively
satisfactory and pointed to an anticipated continuation of growth up to the
period ended 31 March 2009, the Board considers that there are fundamental
reasons why the present business does not provide a long-term basis for the
Company's future viability as an independent entity. The Company is largely
reliant upon its distribution agreement with Wassenburg for its imported
equipment and the vagaries of the Sterling/Euro currency exchange rates mean
that any profit margin on sales can be easily wiped out by a small change in the
exchange rates.


The sale of DIL is subject, inter alia, to the consent of shareholders of DMS.
Conditional upon the completion of the sale of DIL, John Crispin and Mark
Adamson will cease to be directors of DMS, but will continue as directors of
DIL.


The Directors of DMS believe that, having explored other sales opportunities,
the sale of DIL at the above price is the best return that can be expected.
Following the sale, the Company will be an investing company with net cash
resources of approximately GBP800,000 being the proceeds of the sale, which,
together with available bank finance will be utilised for the proposed investing
policy.


In the 18 months to 31 March 2009, DIL reported an audited loss on ordinary
activities before taxation of GBP473,410 (year ended 30 September 2007:
GBP571,508) on a turnover of GBP12,209,849 (year ended 30 September 2007:
GBP4,976,158). During this period, DIL issued 2,184,500 new shares at par to the
Company to strengthen its balance sheet. At 31 March 2009, DIL had net assets of
GBP83,870 (30 September 2007 net liabilities: GBP1,627,220).


A more detailed explanation of the trading performance of DIL will be provided
in the circular to shareholders referred to below.


Following the sale of DIL, DMS will become an investing company for AIM Rules
purposes and its proposed investing policy will require approval by shareholders
of DMS. Following completion of the Sale the Continuing Directors, being Kevin
Gilmore, Gordon Arbib and Nicholas Trigg, propose that, instead of winding up
the Company, the Company's share capital should remain admitted to trading on
AIM and that the Company's New Investing Policy should be based predominantly
upon the acquisition for and development of and/or investment in commercial
property, commercial property agency and the acquisition of land for and
development of high end residential property, together with potential corporate
acquisitions, the latter mainly in the property sector.


A circular will be despatched to DMS shareholders as soon as reasonably
practicable, which will provide further details of the sale and the reasons for
the sale, and convening two general meetings, the first to approve the sale of
DIL and the DMS' proposed investing policies under the AIM Rules (which will be
ordinary resolutions) and the second to approve the change of name of DMS (which
will be a special resolution).

3 July 2009

Enquiries:

Kevin Gilmore
Chairman
DawMed Systems plc01608 682244


Roland Cornish
Chairman
Beaumont Cornish Limited 020 7628 3396

This information is provided by RNS
The company news service from the London Stock Exchange
END

DISBLGDRGBGGGCX

[freestyle] 19/6/2009 12:20

Now that the talks are over it's back to the doldrums

[gelp] 04/6/2009 10:57

Any more thoughts? 2nd on top lists so far and seems more trades than usual.

[freestyle] 22/5/2009 12:07

Gelp,

Thanks for your thoughts, done a little trawling on analyists side and have come up blank.

Suppose I'll have to wait and see.

[gelp] 22/5/2009 08:05

sp rose in march cos of RNS loss to profits etc great imp share price up.the deals since then are insignificant surely.the share price is reacting to the announcements.
who are likely to be interested/benfit from a deal with long established op in the decom/medical field..
Synergy , tristel, ?? must be others as well + international suppliers.
Freestyle says mcap but i think means value. assetts inc good will + multiple of fwd earns - interesting guess work.
At present mc is sitting duck surely.Listing costs alone would go if taken by other listed or larger co.

[frankiestheone] 22/5/2009 00:14

where do you get the mrk cap of 5-6mln from

[freestyle] 21/5/2009 20:09

down today, like the build up to the announcement of the approach I think someone might know if the approach has been stymid hence the movement. pure speculation but that my thoughts. then again never say never until the rotund lady sings.

[freestyle] 20/5/2009 15:43

OK chaps,

Pure speculation thread. I've held these since first listing be intertested to hear of your thoughts for price to be paid for the company and how it will be paid should the approach turn into a takeover. My thoughts are:

Market cap of the company £5-6M, paid for cash.approx 25-30p per share

Be interesting to see how much the intangibles will be costed at, patents, brands etc.

[jambo172] 18/5/2009 10:05

Hope they don't give it away at a cheap price.
Turnover >£7m, profitable and good order book.

Please be greedy on price!

[devbod] 16/5/2009 13:30

Takeover approach! Announced after market close last night. Now if its over 22p a share I might break even ;)

[freestyle] 28/4/2009 22:53

Whilst I doubt that the swine flu outbreak will have a direct effect on DAWMED, I expect that it will act as a reminder to the various hospital authorities and local clinics on the importance of sterilisation of equipment. I suppose one of the advantages of the clinic is it's small size and portability. Ideal for small surgeries.

[mjcrockett] 28/2/2009 09:14

Agree with you there, Gelp.

I notice that Dawmed, like many other tiny AIM companies, is running out of Market Makers. A year ago they had 4 market makers covering the stock but today Winterfloods is the only one. This does lead to a wider spread and tends to increase volatility with the price moving a lot on low volume.

MJ

[gelp] 28/2/2009 09:08

Not hard to see why the the share is being rerated - the interim report clearly showed optimism & recovery improgress & profit forcast - but no body either read it or believed it as was so long coming!
I think we misread the accounting date change as a negative and assumed 12 month figures would be depressed - looks like there was no ulterior motive at all.
The price just continually drifted down & accellerated due to the market conditions.
In spite of the banks efforts to drag every one else down life does go on & I guess that a combination of long experience and close supplier support and determination plus perhaps a liitle luck (the harder you work the luckier you get..!) have enable a genuine improvement on all fronts.
The lows in price were never really available in any numbers (the tripling has to be viewed in context) & i guess those in similar markets will be viewing the lowly valuation with interest as will the directors if the price does not seriously respond to the better news.
Well done Directors for keeping the news really quiet - no leakages!

[powwow] 27/2/2009 11:24

no chatter here.. price trebled.